Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: PDT

VUCA Health's Digital Patient Education Solution, MedsOnCue, Now Allows Pharmacies to Go Paperless in All 50 States and the District of Columbia


LAKE MARY, Fla., July 9, 2020 /PRNewswire/ -- For years, VUCA Health has been advocating for a digital alternative to prescription information that pharmacies traditionally provide on paper. Today, the company announced it has confirmed that pharmacies in all 50 states and the District of Columbia can allow their patients to opt-in to receive their medication information through an eco-friendly, digital platform, instead of on paper.

VUCA's paperless solution, called MedsOnCue, allows patients to access educational information about their medication through a QR code printed on their prescription bottle. Patients also get access to a short video about their prescription and can even view a high-resolution image of their medication.

VUCA began its Going Green campaign in 2015, where it has been working directly with Executive Directors and State Boards of Pharmacies to advocate for a digital alternative to traditional methods of providing prescription information. In addition to an eco-friendly alternative to stapling paper to a bag, pharmacies can save time and money on the costs associated with printing paper for their patients.

As pharmacies learn to operate in an environment battling COVID-19 and prepare for a busy vaccine season, pharmacies across the country currently utilizing MedsOnCue have seen the value in reduced contact by going paperless while being able to provide patient education.

"Pharmacies have been at the forefront of the COVID response during the pandemic," said Richard Waithe, PharmD, President of VUCA Health. "Understanding how difficult it is to run a pharmacy during these hard times where every penny counts and every minute matters, we're happy to help pharmacies across the nation save money and time by going paperless with MedsOnCue."

Visit www.vucahealth.com/gopaperless to learn more.

About VUCA Health

VUCA Health provides a gateway to patient engagement that serves as an on-demand extension of pharmacists and other healthcare providers. The company has built the most extensive library of medication education videos, available in English and Spanish, that can be integrated into websites, mobile apps, and patient portals. Learn more at www.vucahealth.com and connect on TwitterFacebook, and Instagram @VUCAhealth.

Media Contact:
Richard Waithe
Phone: 866-848-8822
Email: [email protected]

Related Images

vuca-health.png
VUCA Health

SOURCE VUCA Health


These press releases may also interest you

at 09:38
The Wyatt Foundation and The Conceive Fertility Foundation announce today a joint partnership that will award $15,000 grants to five individuals/couples who need in vitro fertility (IVF) to build their families. Launching during National Infertility...

at 09:38
New platform and surgery center investment adds advanced facility capabilities to specialty care network, strengthening in-person treatment and attracting leading orthopedic surgeons and physiciansWith Theater launch, value-based MSK care visionary...

at 09:34
The below resolutions were passed at Medicover's annual general meeting (the "AGM") held today on 26 April 2024. Election of the board of directors and auditor The AGM resolved, in accordance with the proposal from the nomination committee, that the...

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...



News published on and distributed by: